The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells

Cancer Letters

Volumn 115, Issue 1, 1997, Pages 73-79

  Oberlies, Nicholas H ^a   Croy, Vicki L ^a   Harrison, Marietta L ^a   McLaughlin, Jerry L ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Acetogenins; Bullatacin; Mammary adenocarcinoma; Multidrug resistance; P gp

Indexed keywords

ACETOGENIN; ADENOSINE TRIPHOSPHATE; BULLATACIN;

ARTICLE; BREAST ADENOCARCINOMA; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOSTASIS; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL DIVISION; DRUG RESISTANCE, MULTIPLE; FURANS; HUMANS; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0031149817     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)04716-2     Document Type: Article

References (27)

1. [1] Goldstein, L.J. (1995) Clinical reversal of drug resistance, Curr. Prob. Cancer, 19, 65-123.
2. [2] van der Heyden, S., Gheuens, E., De Bruijn, E., Van Oosterom, A. and Maes, R. (1995) P-glycoprotein: clinical significance and methods of analysis, Crit. Rev. Clin. Lab. Sci., 32, 221-264.
3. [3] Simon, S.M. and Schindler, M. (1994) Cell biological mechanisms of multidrug resistance in tumors, Proc. Natl. Acad. Sci. USA, 91, 3497-3504.
4. [4] Ruetz, S. and Gros, P. (1994) A mechanism for P-glycoprotein action in multidrug resistance: are we there yet?, Trends Pharm. Sci, 15, 260-263.
5. [5] Gottesman, M.M., Ambudkar, S.V., Ni, B., Arnn, J.M., Sugimotto, Y., Cardarelli, C.O. and Pastan, I. (1994) Exploiting multidrug resistance to treat cancer, Cold Spring Harb. Symp. Quant. Biol., 59, 677-683.
6. [6] Gottesman, M.M. and Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu. Rev. Biochem., 62, 385-427.
7. [7] Ling, V. (1992) P-Glycoprotein and resistance to anticancer drugs, Cancer Res., 69, 2603-2609.
8. [8] Zeng, L., Ye, Q., Oberlies, N.H., Shi, G., Gu, Z.-M., He, K. and McLaughlin, J.L. (1996) Recent advances in Annonaceous acetogenins, Nat. Prod. Rep., 13, 275-306.
9. [9] Gu, Z.-M., Zhao, G.-X., Oberlies, N.H., Zeng, L. and McLaughlin, J.L. (1995) Annonaceous acetogenins: potent mitochondrial inhibitors with diverse applications. In: Recent Advances in Phytochemistry, Vol. 29, pp. 249-310. Editors: J.T. Arnason, R. Mata, and J.T. Romeo. Plenum Press, New York.
10. [10] Fang, X.-P., Rieser, M.J., Gu, Z.-M., Zhao, G.-X. and McLaughlin, J.L. (1993) Annonaceous acetogenins: an updated review, Phytochem. Anal., 4, 27-67.
11. [11] Rupprecht, J.K., Hui, Y.-H. and McLaughlin, J.L. (1990) Annonaceous acetogenins: a review, J. Nat. Prod., 53, 237-278.
12. [12] Lewis, M.A., Arnason, J.T., Philogene, B.J.R., Rupprecht, J.K. and McLaughlin, J.L. (1993) Inhibition of respiration at site I by asimicin, an insecticidal acetogenin of the pawpaw, Asimina triloba (Annonaceae). Pestic. Biochem. Physiol., 45, 15-23.
13. [13] Ahammadsahib, K.I., Hollingworth, R.M., McGovren, J.P., Hui, Y.-H. and McLaughlin, J.L. (1993) Mode of action of bullatacin: a potent antitumor and pesticidal Annonaceous acetogenin, Life Sci., 53, 1113-1120.
14. [14] Londershausen, M., Leicht, W., Lieb, F., Moeschler, H. and Weiss, H. (1991) Molecular mode of action of annonins, Pestic. Sci., 33, 427-438.
15. [15] Morré, J.D., DeCabo, R., Farley, C., Oberlies, N.H. and McLaughlin, J.L. (1995) Mode of action of bullatacin, a potent antitumor acetogenin: inhibition of NADH oxidase activity of HeLa and HL-60, but not liver, plasma membranes, Life Sci., 56, 343-348.
16. [16] Oberlies, N.H., Jones, J.L., Corbett, T.H., Fotopoulos, S.S. and McLaughlin, J.L. (1995) Tumor cell growth inhibition of Annonaceous acetogenins in an in vitro disk diffusion assay, Cancer Lett., 96, 55-62.
17. [17] Monk, A., Scudiero, D., Skelhan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronice, P., Vagio-Wolff, A., Gray-Goodrich, M., Cambell, H., Mayo, J. and Boyd, M. (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines, Cancer, 83, 757-766.
18. [18] Desai, P.B., Bhardwaj, R. and Damle, B. (1995) Effect of tamoxifen on mitoxantrone cytotoxicity in drug-sensitive and multidrug-resistant MCF-7 cells, Cancer Chemother. Pharmacol., 36, 368-372.
19. [19] Yang, C.-P.H., DePinho, S.G., Greenberger, L.M., Arceci, R.J. and Horwitz, S.B. (1989) Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus, J. Biol. Chem., 264, 782-788.
20. [20] Inaba, M. and Maruyama, E. (1988) Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with special emphasis on quinacrine, Cancer Res., 48, 2064-2067.
21. [21] Shiraishi, M., Akiyama, S.-I., Kobayashi, M. and Kuwano, M. (1986) Lysosomotropic agents reverse multiple drug resistance in human cancer cells, Cancer Lett., 30, 251-259.
22. [22] Willingham, M.C., Cornwell, M.M., Cardarelli, C.O., Gottesman, M.M. and Pastan, I. (1986) Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs, Cancer Res., 46, 5941-5946.
23. [23] Tsuruo, T., Iida, H., Tsukagoshi, S. and Sakurai, Y. (1983) Potentiation of vincristine and adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors, Cancer Res., 43, 2267-2272.
24. [24] Sikic, B.I. (1993) Modulation of multidrug resistance: at the threshold, J. Clin. Oncol., 11, 1629-1635.
25. [25] McKeenhan, W.L. and Ham, R.G. (1976) Stimulation of clonal growth of normal fibroblasts with substrata coated with basic polymers, J. Cell Biol., 71, 727-734.
26. [26] Hall, A.M., Croy, V., Chan, T., Ruff, D., Kuczek, T. and Chang, C.-j. (1996) Bicinchoninic acid protein assay in the determination of adriamycin cytotoxicity modulated by the MDR glycoprotein, J. Nat. Prod., 59, 35-40.
27. [27] Gupta, K.P., Ward, N.E., Gravitt, K.R., Bergman, P.J. and O'Brian, C.A. (1996) Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-α pseudosubstrate peptide, J. Biol. Chem., 271, 2102-2111.